A Comprehensive Review of Myocardial Bridging: Exploring Diagnostic and Treatment Modalities

Endurance O Evbayekha1, Enyioma Nwogwugwu2, Adedoyin Olawoye3

  • 1Internal Medicine, St. Luke's Hospital, Chesterfield, USA.

Cureus
|September 11, 2023
PubMed

Insights

Myocardial bridging (MB) is a congenital heart defect where heart muscle covers a coronary artery. Diagnosis and treatment are crucial for preventing serious cardiac events and improving patient outcomes.

Area of Science:

  • Cardiology
  • Congenital Heart Disease

Background:

  • Myocardial bridging (MB) is a congenital coronary artery anomaly.
  • It involves myocardial encasement of a coronary artery segment, potentially causing obstruction.

Purpose of the Study:

  • To review diagnostic and management strategies for myocardial bridging.
  • To highlight the importance of a comprehensive approach to reduce associated morbidity and mortality.

Main Methods:

  • Review of invasive diagnostic modalities: intravascular ultrasound (IVUS) and coronary angiography.
  • Evaluation of non-invasive methods: Doppler ultrasound, multislice computed tomography (MSCT), and magnetic resonance imaging (MRI).
  • Assessment of treatment options including pharmacological agents and interventions.

Main Results:

  • Both invasive and non-invasive methods demonstrate high diagnostic accuracy for MB.
  • Non-invasive techniques offer advantages in terms of safety and cost-effectiveness.
  • Pharmacological and interventional treatments are effective in managing MB symptoms and outcomes.

Conclusions:

  • Myocardial bridging is a treatable cardiac anomaly.
  • A combined approach of accurate diagnosis, timely treatment, and diligent follow-up is essential.
  • Effective management strategies can significantly reduce mortality and morbidity associated with MB.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14